Introduction
============

Patients with dementia and musculoskeletal disease often require nursing care in Japan.[@b1-cia-12-1451] Dementia is a progressive disorder of the brain. The damage to brain cells as a consequence of dementia results in a loss of cognitive ability, including the ability to think, reason, and function. This leads to a reduction in quality of life (QOL), for example, by affecting daily activities, including the ability to take care of oneself. As the signs and symptoms of dementia worsen, the disorder also affects the lives and emotional wellbeing of families and caregivers.[@b2-cia-12-1451] Current global estimates suggest that more than 46.8 million people are affected by dementia.[@b3-cia-12-1451] Among Japanese people who are over 65 years old, 2.6 million people are affected by dementia, with a prevalence rate of approximately 8.4%.[@b4-cia-12-1451]

Motor function decreases with age and also leads to a decrease in activities of daily living and QOL. The physical activity level of elderly people living in the community and their health-related QOL are closely related.[@b5-cia-12-1451],[@b6-cia-12-1451] The frailty criteria proposed by Fried et al are most frequently used in clinical practice, and comprise three or more of five conditions: slowness, weakness, shrinking, inactivity, and exhaustion.[@b7-cia-12-1451] Frailty is a state of increased vulnerability to adverse outcomes, including disability, owing to poor resolution of homoeostasis after a stressor event.[@b8-cia-12-1451] A close association between frailty and dementia has been demonstrated.[@b9-cia-12-1451]

A concept referred to as locomotive syndrome (LS) was proposed by the Japanese Orthopaedic Association to help identify middle-aged and older adults who may be at high risk of requiring healthcare services. This risk increases as a person's movement function deteriorates due to locomotive impairment. Some causes of LS are reduced muscle strength and balance associated with aging and conditions due to osteoporosis, osteoarthritis, and sarcopenia.[@b10-cia-12-1451] At present, concepts of LS, sarcopenia, and frailty have many things in common, but the distinction among them is ambiguous. The concept of LS includes social significance in which people's understanding of locomotion leads to attention toward motor disorders. The proportion of the Japanese population with LS (47 million) is estimated to be more than twice that with metabolic syndrome (20 million).[@b11-cia-12-1451],[@b12-cia-12-1451] We evaluated LS status using the 25-question Geriatric Locomotive Function Scale (GLFS-25 or Locomo-25) score. The GLFS-25 is a self-completed questionnaire that consists of 25 items, including four questions on pain during the last month, 16 questions on activities of daily activity during the last month, three questions on social functions, and two questions on mental health status during the last month.[@b13-cia-12-1451] These 25 items are scored from 0 (no impairment) to 4 (severe impairment), and the total score ranges from 0 to 100 points. Higher scores indicate worse locomotive function, and the cut-off score for LS is 16 points. The validity of the GLFS-25 was confirmed by demonstrating a significant correlation with the European Quality of Life Scale-5 Dimensions questionnaire.[@b13-cia-12-1451] Many reports have suggested that the GLFS-25 score strongly correlates with several measures of physical performance, including the walking speed test, handgrip strength test, unipedal stance test, and the timed up and go test.[@b14-cia-12-1451]--[@b18-cia-12-1451] The age-associated reduction in muscle mass in sarcopenia is also associated with cognitive dysfunction.[@b19-cia-12-1451]--[@b21-cia-12-1451] Momoki et al have reported that LS is associated with sarcopenia,[@b22-cia-12-1451] which is also related to cognitive decline and dementia.[@b23-cia-12-1451]

A depressive state is frequently observed in patients with mild cognitive impairment (MCI) and dementia.[@b24-cia-12-1451]--[@b26-cia-12-1451] Recently, we reported that comparative analysis between LS and non-LS subjects revealed significant differences in the degree of depression with age.[@b27-cia-12-1451],[@b28-cia-12-1451]

Medications and social policies are urgently needed to reduce and prevent cognitive impairment and LS in older adults living in the community. No studies have investigated the relationship between cognitive function and LS. Therefore, the purpose of this study was to determine the association between LS and cognitive status, with the goal of providing information that will help prevent LS and dementia in community-dwelling elderly people. If the relationship between LS and cognitive impairment becomes clear, mutual prevention of LS and cognitive decline will be expected to prevent onset of LS and dementia in community-dwelling individuals.

Participants
------------

This study was conducted in a local area (Kaizuka City, Osaka Prefecture, Japan) between August 2016 and March 2017. The study inclusion criteria were: 1) Japanese women, aged ≥60 years, and 2) living independently in their own home. All participants initially underwent measurement of blood pressure and body composition, followed by evaluation of cognitive function and LS status at a public hall where a "Lecture meeting and checkup for health," supported by the local government in Kaizuka, Osaka, was held. A total of 142 participants (mean age 74.26±5.86 years; range 60--90 years) were considered for the present analysis. All participants provided written informed consent to be part of the entire research. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Osaka Kawasaki Rehabilitation University (Reference No OKRU28-A014).

Measurement of variables
------------------------

Systolic and diastolic blood pressure was measured with a Mercury tabletop blood pressure monitor (Sankei Co., Chiba, Japan).

The total body weight, percent body fat, and skeletal muscle mass index (SMI) were obtained from the electronic medical records of InBody270 (InBody, Tokyo Japan), which estimates body composition using frequencies (20 and 1,000 kHz). Participants were instructed to grasp the handles of the analyzer in which electrodes are embedded and to stand on electrodes that contact the bottoms of their feet while wearing normal indoor clothing without socks and shoes. The body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.

Evaluation of cognitive function
--------------------------------

Cognitive function was assessed using the Mini-Mental State Examination (MMSE), which assesses global cognition including orientation, registration, attention, calculation, language, and recall.[@b29-cia-12-1451] MMSE scores range from 0 to 30, with higher scores indicating better cognitive function. A pre-specified score of ≤26 on MMSE was used to indicate categorically defined poor performance.[@b30-cia-12-1451]

Assessment of LS status
-----------------------

The LS status was evaluated using the 25-question GLFS-25 or Locomo-25 score. The GLFS-25 is a self-administered questionnaire that comprises four questions about pain during the last month, 16 questions about activities of daily living during the last month, three questions about social function during the last month, and two questions about mental health status during the last month.[@b13-cia-12-1451] All 25 questions are scored from 0 (no impairment) to 4 (severe impairment), and the total score ranges from 0 to 100. Higher scores indicate worse locomotive function, and a pre-specified score of ≥16 was considered indicative of LS.[@b13-cia-12-1451]

Statistical analysis
--------------------

Participants were categorized into a cognitive impairment group (MMSE score ≤26) or a non-impairment group (MMSE score \>26), and into an LS group (GLFS-25 score ≥16) or a non-LS group (GLFS-25 score \<16). Independent variables were compared between the cognitive MMSE \>26 and MMSE ≤26 groups, and between the LS and non-LS groups. For numerical variables (age, BMI, percent body fat, SMI, GLFS-25 score, and MMSE score), the normality of distribution and homogeneity of variance were tested prior to comparison across groups. The Student's *t*-test was used when assumptions of normal distribution and homogeneity of variance were fulfilled in both groups; Welch's *t*-test was used when the assumption of normal distribution was met, but the assumption of homogeneity of variance was not; and the Wilcoxon signed-rank test was used when the data were not normally distributed. The odds ratios (ORs) of measurements or LS status for an MMSE score ≤26 were calculated using univariate and multiple logistic regression analysis. Age, percent body fat, GLFS score, and LS were used as independent variables, and MMSE ≤26 as a dependent variable. Logistic regression model 1 was adjusted for age, and model 2 was adjusted for age and percent body fat. The GLFS-25 threshold score for discriminating the MMSE \>26 group and the MMSE ≤26 group was evaluated using receiver operating curve (ROC) analysis. The ORs of MMSE ≤26 for the GLFS-25 threshold score were calculated using multiple logistic regression analysis. Age and percent body fat were used as independent variables, and MMSE ≤26 as a dependent variable. Logistic regression model 1 was adjusted for age, and model 2 was adjusted for age and percent body fat. All *p*-values and 95% confidence intervals (CI) of two-sided analysis are presented. Statistical analysis was conducted using JMP 11 (SAS Institute, Cary, NC). All statistical tests were two-tailed, and a significance level of 0.05 was used.

Results
=======

Characteristics of the study participants
-----------------------------------------

Age, blood pressure, height, total body weight, BMI, percent body fat, SMI, MMSE score, and GLFS-25 score are shown in [Table 1](#t1-cia-12-1451){ref-type="table"}. Twenty-one participants (14.8%) had an MMSE score ≤26, and 27 participants (19.0%) had a GLFS-25 score ≥16. These proportions increased in older participants ([Table 2](#t2-cia-12-1451){ref-type="table"}).

Comparison of characteristics between the MMSE \>26 and ≤26 groups
------------------------------------------------------------------

The cognitive impairment group (MMSE ≤26) was older, had a higher BMI, a higher percent body fat, a lower SMI, and a higher GLFS-25 score than the \>26 group. Significant differences were observed between the two groups in age, percent body fat, and GLFS-25 score ([Table 3](#t3-cia-12-1451){ref-type="table"}).

Comparison of characteristics between GLFS-25 \<16 and ≥16 groups
-----------------------------------------------------------------

The LS group (GLFS-25 ≥16) was older, had a higher BMI, a higher percent body fat, a lower SMI, and a lower MMSE score than the \<16 group. Significant differences between the two groups in age, BMI, percent body fat, and MMSE score were observed ([Table 3](#t3-cia-12-1451){ref-type="table"}). Furthermore, the chi-square test showed a relationship between cognitive impairment and LS status (*p*\<0.01; [Table 3](#t3-cia-12-1451){ref-type="table"}).

ORs of characteristics for MMSE ≤26
-----------------------------------

[Table 4](#t4-cia-12-1451){ref-type="table"} shows univariate and multiple logistic regression analysis results for ORs of each measurement, including age, percent body fat, and GLFS-25 scores, which showed significant differences between an MMSE score \>26 and ≤26, as shown in [Table 3](#t3-cia-12-1451){ref-type="table"}. Univariate logistic regression analysis showed that age (OR=1.10, 95% CI=1.02--1.20; *p*\<0.05), percent body fat (OR=1.10, 95% CI=1.02--1.21; *p*\<0.05), GLFS-25 score (OR=1.06, 95% CI=1.03--1.09; *p*\<0.001), and LS status (OR=4.29, 95% CI=1.55--11.69; *p*\<0.01) were significantly associated with low cognition. Multiple logistic regression model 1, which was adjusted for age, showed that percent body fat (OR=1.09, 95% CI=1.01--1.19; *p*\<0.05), GLFS-25 score (OR=1.05, 95% CI=1.02--1.09; *p*\<0.001), and LS status (OR=3.08, 95% CI=1.03--9.09; *p*\<0.05) were significantly associated with low cognition. Model 2, which was adjusted for age and percent body fat, showed that the GLFS-25 score (OR=1.04, 95% CI=1.01--1.08; *p*\<0.005) was significantly associated with low cognition, whereas LS status was not ([Table 4](#t4-cia-12-1451){ref-type="table"}).

Threshold score of GLFS-25 for MMSE ≤26 and ORs of GLFS-25 threshold for MMSE ≤26
---------------------------------------------------------------------------------

The ROC analysis of GLFS-25 scores showed a threshold score of 6 for discriminating the MMSE \>26 group and the MMSE≤26 group (AUC=0.72, sensitivity=85.7%, and specificity=50.4%; [Table 5](#t5-cia-12-1451){ref-type="table"}).

Logistic regression model 1 adjusted for age showed that participants with a GLFS-25 score ≥6 had an OR of 4.44 odds for MMSE ≤26 (95% CI=1.28--20.87; *p*\<0.05), and model 2 adjusted for age and percent body fat showed that participants with a GLFS-25 score ≥6 had OR of 4.12 odds for MMSE ≤26 (95% CI=1.17--19.46; *p*\<0.05; [Table 6](#t6-cia-12-1451){ref-type="table"}).

Discussion
==========

Our results showed that the cognitive impairment group had a lower SMI, a higher BMI, and a higher percent body fat than the \>26 group. This observation is consistent with previous reports showing that central obesity is associated with cognitive decline and that patients with Alzheimer's disease had lower lean tissue mass and a higher percent fat mass.[@b31-cia-12-1451],[@b32-cia-12-1451] Similarly, the LS group also had a lower SMI, a higher BMI, and a higher percent body fat than the non-LS group. This result is consistent with our previous reports.[@b28-cia-12-1451],[@b33-cia-12-1451] These results suggested that both cognitive impairment and LS are correlated with body composition parameters.

Ikemoto et al have reported that no significant differences are present between non-LS and LS with regard to cognitive status.[@b27-cia-12-1451] However, we found significant differences between LS status regarding the MMSE score. This difference may be due to the gender difference of the subjects; the Ikemoto et al report did not describe the details of the subjects. On the other hand, we observed a significant difference in the GLFS-25 score among the MMSE groups, and the LS group had significantly higher odds of having cognitive impairment than the group without LS in multiple regression model 1, which is adjusted for age. Previous studies have reported that cognitive decline and dementia are associated with motor dysfunction or low physical activity, including slower gait speed in the elderly.[@b34-cia-12-1451],[@b35-cia-12-1451] Furthermore, many reports have shown that an exercise intervention improves cognitive function in older people.[@b36-cia-12-1451] Thus, the process of cognitive deterioration, which is caused by a decrease in motor function as defined by LS at first, occurs in many elderly people. Then, a vicious cycle may ensue in which cognitive decline leads to impairment in motor function due to low physical activity; furthermore, an impairment in motor function causes further cognitive impairment. Slow walking speed, a component of frailty, is also significantly associated with MCI[@b37-cia-12-1451] and future development of MCI.[@b38-cia-12-1451] Subjective cognitive impairment, in combination with slow gait speed, has been defined as motoric cognitive risk syndrome,[@b39-cia-12-1451] which is a risk factor for future development of dementia.[@b40-cia-12-1451] This concept strongly supports our present results.

Cerebellar injury leads to impairment in various cognitive functions.[@b41-cia-12-1451] Recently, the cerebellum has been reported to not only be involved in motor function but also in processing of sensorimotor, cognitive, and affective information.[@b42-cia-12-1451],[@b43-cia-12-1451] Furthermore, a relationship between dementia, including Alzheimer's disease, and cerebellar atrophy was recently reported.[@b44-cia-12-1451] Therefore, the cerebellum is involved not only in motor functions but also in higher functions. Schmahmann and Sherman proposed a concept of disease called "cerebellar cognitive affective syndrome," which is characterized by impairment of executive functions, difficulties with spatial cognition, personality changes, and language deficits.[@b45-cia-12-1451] On the other hand, significant ORs of the GLFS-25 threshold score for cognitive impairment were detected in both models 1 and 2. The Japan Orthopedic Surgery Society proposes that GLFS-25 identifies an initial decline in motor function at 7 points or more, and that GLFS-25 identifies a progressive decline in motor function with a score of more than 16 points.[@b46-cia-12-1451] These findings suggest that a strong relationship exists between the early stage of decreased motor function and cognitive impairment. In other words, when an intervention is undertaken in the early stage of motor function deterioration, the possibility of preventing deterioration of cognitive function exists. A longitudinal study is needed to clarify this idea.

Limitations and future research
===============================

This study has several limitations. First, the sample size of 142 was small; this number represents approximately 1.0% of all women aged 60--90 years in Kaizuka City. Further research in larger-sized studies is needed. Second, because the participants in this study were all Japanese women, care should be taken in generalizing the results to men or other ethnic groups. Third, data from a cross-sectional study are insufficient to determine whether a causal relationship exists between cognitive status and LS. Conducting longitudinal studies to clarify the causal relationships among these factors is, therefore, crucial. Fourth, because we have no information on participants' lower back pain, knee pain, or physical inactivity, which are confounding factors for LS, or for nutritional balance, family relationships, economic situation, or education history, which are confounding factors for cognitive impairment, we cannot conclude how these factors may have affected the results.

Conclusion
==========

The LS group had higher odds of having cognitive impairment than the group without LS. These findings suggest a close relationship between LS and cognitive impairment.
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###### 

Characteristics of the study participants

  Variables for components          Average (SD)
  --------------------------------- ----------------
  Age (years)                       74.26 (5.86)
  Systolic blood pressure (mmHg)    135.95 (15.23)
  Diastolic blood pressure (mmHg)   75.27 (11.03)
  Height (cm)                       150.52 (5.34)
  Total body weight (kg)            51.37 (7.22)
  BMI (kg/m^2^)                     22.70 (3.24)
  Percent body fat (%)              32.55 (6.60)
  SMI (kg/m^2^)                     5.61 (0.66)
  GLFS-25 (points)                  10.63 (13.27)
  MMSE (points)                     28.46 (2.03)

**Note:** Values are presented as mean ±SD).

**Abbreviations:** BMI, body mass index; GLFS-25, 25-question Geriatric Locomotive Function Scale; MMSE, Mini-Mental State Examination; SD, standard deviation; SMI, skeletal muscle mass index.

###### 

Number and percentage of MMSE and GLFS-25 classifications by age

  -----------------------------------------------------------------------
  Age\      Total   MMSE          GLFS-25                    
  (years)                                                    
  --------- ------- ------------- ------------ ------------- ------------
  Total     142     121 (85.2%)   21 (14.8%)   115 (81.0%)   27 (19.0%)

  60--70    35      34 (97.1%)    1 (2.9%)     34 (97.1%)    1 (2.9%)

  71--80    88      72 (81.8%)    16 (18.2%)   70 (79.5%)    18 (20.5%)

  81--90    19      15 (78.9%)    4 (21.1%)    11 (57.9%)    8 (42.1%)
  -----------------------------------------------------------------------

**Abbreviations:** GLFS-25, 25-question Geriatric Locomotive Function Scale; MMSE, Mini-Mental State Examination.

###### 

Comparison of characteristics between the MMSE groups and GLFS-25 groups

                           MMSE           GLFS-25                                                                                          
  ------------------------ -------------- --------------- -------------------------------------------------- -------------- -------------- ----------------------------------------------------
  Age (years), mean (SD)   73.76 (5.87)   77.14 (5.01)    0.014[a](#tfn5-cia-12-1451){ref-type="table-fn"}   73.22 (5.56)   78.70 (5.00)   \<0.001[a](#tfn5-cia-12-1451){ref-type="table-fn"}
  BMI (kg/m^2^)            22.54 (3.21)   23.65 (3.38)    0.147[a](#tfn5-cia-12-1451){ref-type="table-fn"}   22.25 (3.11)   24.04 (3.13)   \<0.001[a](#tfn5-cia-12-1451){ref-type="table-fn"}
  Percent body fat         32.00 (6.07)   35.73 (4.97)    0.016[a](#tfn5-cia-12-1451){ref-type="table-fn"}   31.45 (6.36)   37.26 (5.49)   \<0.001[a](#tfn5-cia-12-1451){ref-type="table-fn"}
  SMI (kg/m^2^)            5.66 (0.60)    5.34 (0.87)     0.051[b](#tfn6-cia-12-1451){ref-type="table-fn"}   5.63 (0.64)    5.53 (0.75)    0.483[a](#tfn5-cia-12-1451){ref-type="table-fn"}
  MMSE (points)                                                                                              28.69 (1.79)   27.52 (2.68)   0.039[d](#tfn8-cia-12-1451){ref-type="table-fn"}
  GLFS-25 (points)         8.69 (10.11)   21.81 (21.76)   0.001[b](#tfn6-cia-12-1451){ref-type="table-fn"}                                 
  Non-LS (%)               103 (85.1)     12 (57.1)       0.006[c](#tfn7-cia-12-1451){ref-type="table-fn"}                                 
  LS (%)                   18 (14.9)      9 (42.9)                                                                                         

**Notes:** Values are presented as mean (SD).

Student's *t*-test;

Wilcoxan signed-rank test;

Chi-square test;

Welch's *t*-test.

**Abbreviations:** MMSE, Mini-Mental State Examination; SD, standard deviation; BMI, body mass index; SMI, skeletal muscle mass index; GLFS-25, 25-question Geriatric Locomotive Function Scale; LS, locomotive syndrome (GLFS-25 score ≥16 points).

###### 

Odds ratios of characteristics for MMSE ≤26

  Variables for components   Univariate analysis   Logistic regression model 1   Logistic regression model 2                                                   
  -------------------------- --------------------- ----------------------------- ----------------------------- ------ ------------ ------- ------ ------------ -------
  Age                        1.10                  1.02--1.20                    0.015                                                                         
  Percent body fat           1.10                  1.02--1.21                    0.012                         1.09   1.01--1.19   0.033                       
  GLFS-25                    1.06                  1.03--1.09                    \<0.001                       1.05   1.02--1.09   0.004   1.04   1.01--1.08   0.015
  LS                         4.29                  1.55--11.69                   0.006                         3.08   1.03--9.09   0.045   2.21   0.67--7.09   0.190

**Notes:** Univariate and multiple logistic regression analysis involving age, percent body fat, GLFS-25 and LS was performed. Model 1 is adjusted for age, and model 2 adjusted for age and percent body fat.

**Abbreviations:** MMSE, Mini-Mental State Examination; CI, confidence interval; GLFS-25, 25-question Geriatric Locomotive Function Scale; LS, locomotive syndrome (GLFS-25 score ≥16 points).

###### 

Threshold score of GLFS-25 for MMSE ≤26

                     Threshold values   Area under the curve   Sensitivity   Specificity   *p*-value
  ------------------ ------------------ ---------------------- ------------- ------------- -----------
  GLFS-25 (points)   6                  0.72                   0.86          0.50          \<0.0001

**Abbreviation:** MMSE, Mini-Mental State Examination; GLFS-25, 25-question Geriatric Locomotive Function Scale.

###### 

Odds ratios for MMSE ≤26 according to GLFS-25 score

  Variables for components   Logistic regression model 1   Logistic regression model 2                                  
  -------------------------- ----------------------------- ----------------------------- ------- ------ --------------- -------
  GLFS-25 (points)           1                                                           0.018                          0.027
   \<6                                                                                           1                      
   ≥6                        4.44                          (1.28--20.87)                         4.12   (1.17--19.46)   

**Notes:** Multiple logistic regression analysis involving age, percent body fat, GLFS-25 and was performed. Model 1 is adjusted for age, and model 2 adjusted for age and percent body fat.

**Abbreviations:** MMSE, Mini-Mental State Examination; Cl, confidence interval; GLFS-25, 25-question Geriatric Locomotive Function Scale.
